We are currently enrolling qualified applicants into a study of an investigational Postpartum Depression medication.
To participate in this study you must be female and be between 18 – 45 years of age. You must also have Postpartum Depression defined as experiencing a Major Depressive Episode, which started between the start of the third trimester and 4 weeks following delivery. Additionally, you must have given birth in the last 12 months.
If you are eligible for the trial, you will receive the study treatment as an intravenous infusion (IV) for 60 hours. If you choose to take part in the study, you will be admitted to our research unit for 3 days to receive the treatment. There will be 2 safety follow-up visits after you have been discharged from your inpatient stay. All subjects will be allowed to remain on their current antidepressants provided that they have not had a recent change in the medication regimen.
Your first visit to the research clinic will be a screening visit. During this visit you will meet with a study coordinator to fully review study details. If you decide to participate, a more in-depth assessment of your health will take place to determine your final eligibility. If you are eligible and choose to enroll, you will be required to return to our research clinic various times for treatment and follow-up visits.
Space in the study is limited. Health insurance is not required. All clinical visits, medications, and physical exams are provided to you at no cost. You may be compensated for time and travel. If you are unable to complete the study for any reason, you will receive a pro-rated amount based upon the number of visits you complete.
Please complete the form below to see if you pre-qualify for the study.
Disclaimer: Not all individuals that complete the online questionnaire will qualify for the study. An in-depth study and medical evaluation must be completed in person in order to qualify for the study.